Colon cancer often produces no symptoms in its early stages, which is why screening catches many cases before a person notices anything wrong. When it does cause symptoms, the experience depends heavily on how far the cancer has progressed and whether it has spread beyond the colon. Here’s what actually happens in your body, what treatment typically looks like, and what the outlook is at each stage.
How Colon Cancer Develops
Nearly all colon cancers start as small, noncancerous growths called polyps on the inner lining of the colon. Over time, a series of genetic mutations accumulate in these cells. The first mutation, which occurs in about 80% of cases, disables a gene that normally keeps cell growth in check. Additional mutations then pile on, each one pushing cells to grow faster and divide more aggressively. By the time a fourth key mutation takes hold, the cells are fully geared toward rapid, uncontrolled division.
This transformation from harmless polyp to cancer is slow, typically taking 10 to 15 years. That long window is exactly why colonoscopies are so effective: a doctor can find and remove polyps years before they ever become dangerous. The U.S. Preventive Services Task Force recommends screening starting at age 45 for people at average risk.
Symptoms You Might Notice
Early colon cancer is often silent. When symptoms do appear, they depend on the tumor’s size and location in the large intestine. Common signs include:
- A persistent change in bowel habits, such as new diarrhea or constipation
- Rectal bleeding or blood in the stool
- Ongoing belly discomfort: cramps, gas, or pain that doesn’t resolve
- A feeling that your bowel doesn’t fully empty after a movement
- Unexplained weight loss
- Fatigue or weakness that seems out of proportion to your activity level
These symptoms overlap with many less serious conditions, which is part of why colon cancer can go undetected. The key distinction is persistence. A week of unusual bowel habits after a dietary change is unremarkable. Weeks or months of unexplained changes warrant investigation.
What the Stages Mean
Once colon cancer is diagnosed, staging determines how far it has progressed. The stage drives every treatment decision and shapes the overall outlook.
Stage 0 and Stage I mean the cancer is confined to the inner layers of the colon wall. It hasn’t reached nearby lymph nodes or other organs. These are the most treatable stages, and surgery alone is often sufficient.
Stage II means the tumor has grown deeper into or through the colon wall but still hasn’t reached the lymph nodes. Substages (IIA, IIB, IIC) distinguish whether the cancer has broken through the outer wall or attached to nearby tissues. Surgery is the primary treatment, though some higher-risk Stage II cancers may also need chemotherapy.
Stage III means the cancer has reached nearby lymph nodes. This is a significant threshold because lymph node involvement signals that cancer cells have entered a pathway that can carry them elsewhere in the body. Treatment almost always combines surgery with chemotherapy.
Stage IV means the cancer has spread to distant organs. The liver, lungs, abdominal cavity lining, and distant lymph nodes are the most common destinations. Treatment at this stage focuses on controlling the disease and may involve surgery, chemotherapy, targeted therapy, or immunotherapy depending on the specifics.
What Happens When It Spreads
If colon cancer metastasizes, it produces symptoms specific to the organ it reaches. Cancer that spreads to the liver can cause pain in the upper right abdomen, loss of appetite, yellowing of the skin and eyes (jaundice), itchy skin, and a swollen belly from fluid accumulation. Cancer that reaches the lungs may cause a persistent cough, shortness of breath, or coughing up blood.
Metastatic colon cancer doesn’t become liver cancer or lung cancer. The cells are still colon cancer cells growing in a new location, which matters because treatment targets the original cancer type.
What Treatment Looks Like
Surgery
Surgery is the cornerstone of colon cancer treatment for stages I through III, and sometimes for stage IV when the spread is limited. The most common approach is removing the section of the colon containing the tumor along with a margin of healthy tissue on either side. The specific procedure depends on where the tumor sits. A tumor on the right side of the colon requires removing the ascending colon. One on the left side means removing the descending colon and sometimes the upper rectum. Smaller tumors may need only a short segment removed.
In most cases, the surgeon reconnects the remaining sections of the intestine, and normal bowel function eventually returns. When reconnection isn’t safe, typically because the tissue needs time to heal or because the cancer is very low in the rectum, the surgeon creates a small opening in the abdominal wall called a stoma. Waste empties into a bag worn outside the body. This can be temporary (reversed in a later surgery) or permanent, depending on the situation. A permanent colostomy is most common when the cancer requires removing the anus entirely.
Chemotherapy
Chemotherapy after surgery is standard for Stage III colon cancer and some higher-risk Stage II cases. The goal is to kill any cancer cells that may have escaped the tumor before it was removed. The most common regimens combine a platinum-based drug with other cancer-fighting agents, given in cycles over several months.
The most notable side effect is nerve damage in the hands and feet, called neuropathy, which can cause tingling, numbness, or sensitivity to cold. Studies have found that shorter courses of treatment (three months instead of six) dramatically reduce the rate of significant neuropathy, from about 31% down to 9%, while still providing strong protection against recurrence for many patients. Your oncologist will weigh the cancer’s specific risk factors against the side-effect burden when recommending a treatment length.
Immunotherapy
About 5% of people with advanced colon cancer have tumors with a specific biological trait: their cells can’t properly repair certain types of DNA damage during division. These tumors, identified through biomarker testing, respond remarkably well to immunotherapy drugs that help the immune system recognize and attack cancer cells. The FDA has approved several immunotherapy options as initial treatment for these patients, and the response rates are significantly better than with chemotherapy alone. Biomarker testing at diagnosis is now routine to identify who qualifies.
Recovery After Surgery
The weeks after colon surgery require careful dietary adjustments while your digestive system heals. Raw fruits (other than bananas and melons), raw vegetables, beans, and whole grains can cause blockages early on and should be avoided. Caffeine, alcohol, spicy foods, and fatty foods can worsen dehydration or be difficult to digest. Artificial sweeteners may worsen diarrhea.
Soluble fiber supplements, taken two to three times daily, help thicken stool and slow digestion as your body adjusts to operating with less colon. After four to six weeks, you can start reintroducing restricted foods one at a time, trying a small portion and waiting 24 hours to see how your body handles it. Most people eventually return to a normal diet, though individual tolerance varies.
Survival Rates by Stage
Five-year survival rates give the clearest picture of outcomes. According to the most recent SEER data covering 2016 through 2022, the numbers break down by how far the cancer has spread at diagnosis:
- Localized (confined to the colon): 91.3% five-year survival
- Regional (spread to nearby lymph nodes): 75.2%
- Distant (spread to other organs): 16.9%
These are population averages. Individual outcomes vary based on age, overall health, the tumor’s specific biology, and how well it responds to treatment. The numbers also reflect patients diagnosed years ago. Newer treatments, particularly immunotherapy for eligible patients, are improving outcomes for advanced disease in ways not yet fully captured in long-term survival statistics.
The single biggest factor in outcomes is how early the cancer is caught. A localized tumor found during a routine screening colonoscopy carries an entirely different prognosis than a cancer discovered after it has spread to the liver. That gap between 91% and 17% survival is, more than anything, a case for screening on schedule.